Skip to content

奥索儿科

US · KIDS #3642 按市值排名 上市于 2017
21.95 -0.62 -2.75%
实时 - 追踪5344个代码 - 心跳于172秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例下降了5.2个百分点。

机构持股

机构持股比例
90.25% -5.25pp
机构数量
151 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund41.02%
VC/PE Fund24.38%
Hedge Fund19.56%
Individual/Insider6.45%
Public Company3.15%
Private Company1.17%
Insurance Company0.68%
Sovereign Wealth Fund0.24%
Other3.30%

主要股东 截至 2026-09-10

Squadron Capital, LLC 23.75% · 6.20M 股
Brown Advisory Incorporated 6.43% · 1.68M 股
BlackRock 4.87% · 1.27M 股
Braidwell LP 4.21% · 1.10M 股
Granahan Investment Management, LLC 4.16% · 1.09M 股
Vanguard Capital Management, LLC 3.34% · 872.90K 股
Millennium Management LLC 3.13% · 816.83K 股
Wellington Management Group 3.04% · 794.31K 股
Soleus Capital Management, L.P. 2.80% · 732.14K 股
Morgan Stanley 2.64% · 688.60K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 31次买入 · 18次卖出

姓名职务持股比例
Squadron Capital, LLC -- 23.75%
David Bailey Chief Executive Officer 1.60%
Fred Hite CFO, Principal Financial & Accounting Officer, COO and Director 1.06%
Mark Throdahl Executive Chairperson 0.77%
Joseph Hauser President of Trauma & Deformity Correction 0.75%
Gregory Odle President of Scoliosis 0.72%
Daniel Gerritzen Executive VP of Legal & General Counsel 0.56%
David Pelizzon Director 0.17%
Harald Ruf Director 0.16%
Bryan Hughes Independent Director 0.13%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-09 Squadron Capital, LLC -- Open Market Disposition -302,369 $21.01
2026-09-01 Squadron Capital, LLC -- Open Market Disposition -22,500 $23.35
2026-08-31 Squadron Capital, LLC -- Open Market Disposition -336,831 $23.04–23.10
2026-08-25 Squadron Capital, LLC -- Open Market Disposition -38,300 $24.28–25.75
2026-06-08 Mark Throdahl Executive Chairperson Other Acquisition +11,436 --
2026-06-08 Samuel Riccitelli Independent Director Other Acquisition +11,436 --
2026-06-08 David Bailey Chief Executive Officer Other Acquisition +119,140 --
2026-06-08 David Pelizzon Director Other Acquisition +11,436 --
2026-06-08 Bryan Hughes Independent Director Other Acquisition +11,436 --
2026-06-08 Harald Ruf Director Other Acquisition +11,436 --
2026-06-08 Marie Infante Independent Director Other Acquisition +11,436 --
2026-06-08 Jimmy McDonald Independent Director Other Acquisition +11,436 --
2026-06-08 George S. Dyer Independent Director Other Acquisition +11,436 --
2026-06-08 Kelly Fischer Director Other Acquisition +11,436 --
2026-05-12 Daniel Gerritzen Executive VP of Legal & General Counsel Other Disposition -2,479 --
2026-03-15 Fred Hite CFO, Principal Financial & Accounting Officer, COO and Director Open Market Disposition -12,993 $17.25
2026-03-15 David Bailey Chief Executive Officer Open Market Disposition -19,535 $17.25
2026-03-15 Gregory Odle President of Scoliosis Open Market Disposition -8,433 $17.25
2026-03-15 Daniel Gerritzen Executive VP of Legal & General Counsel Open Market Disposition -8,614 $17.25
2026-03-15 Joseph Hauser President of Trauma & Deformity Correction Open Market Disposition -8,596 $17.25

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

奥索儿科 讨论区 0 条评论

发表评论